NSE: NIFTYPHARMA

22225.90 149.10 (0.68%)

NSE 11 Jul, 2025 3:31 PM (IST)

Nifty Pharma PB	5.3
Nifty Pharma PE	31.9
Nifty Pharma DIV	0.9
Nifty Pharma EPS	697.2

Nifty Pharma News, Corporate filings and Earnings/Conference Calls

Name: Latest research reports of Granules India Ltd. authored by Geojit BNP Paribas and published by - Trendlyne research reports.
Item: Granules India Ltd.
Rating: 4
Author: Geojit BNP Paribas

Keep track of all breaking news and updates on Nifty Pharma from all sources in a single place.

Load latest

Is Nifty Pharma worth buying?

317 Votes:

Buy 79.18%

Sell 11.67%

Hold 9.15%